Results 21 to 30 of about 137,667,520 (210)

In Silico Meets in Vivo [PDF]

open access: yes, 2012
A report of the 6th Georgia Tech-Oak Ridge National Lab International Conference on Bioinformatics 'In silico Biology: Gene Discovery and Systems Genomics', Atlanta, USA, 15-17 November ...
Guigo, Roderic, Weng, Zhiping
core   +4 more sources

A Modular Repository-based Infrastructure for Simulation Model Storage and Execution Support in the Context of Oncology and Medicine

open access: yesCancer Informatics, 2016
The plethora of available disease prediction models and the ongoing process of their application into clinical practice – following their clinical validation – have created new needs regarding their efficient handling and exploitation.
Nikolaos A. Christodoulou   +5 more
doaj   +1 more source

How can we discover developable antibody-based biotherapeutics?

open access: yesFrontiers in Molecular Biosciences, 2023
Antibody-based biotherapeutics have emerged as a successful class of pharmaceuticals despite significant challenges and risks to their discovery and development.
Joschka Bauer   +10 more
doaj   +1 more source

DrugBank: a comprehensive resource for in silico drug discovery and exploration

open access: yesNucleic Acids Res., 2005
DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chemical) data with comprehensive drug target (i.e. protein) information.
D. Wishart   +7 more
semanticscholar   +1 more source

A Guide to In Silico Drug Design

open access: yesPharmaceutics, 2022
The drug discovery process is a rocky path that is full of challenges, with the result that very few candidates progress from hit compound to a commercially available product, often due to factors, such as poor binding affinity, off-target effects, or ...
Yiqun Chang   +5 more
semanticscholar   +1 more source

TeachOpenCADD: a teaching platform for computer-aided drug design using open source packages and data

open access: yesJournal of Cheminformatics, 2019
Owing to the increase in freely available software and data for cheminformatics and structural bioinformatics, research for computer-aided drug design (CADD) is more and more built on modular, reproducible, and easy-to-share pipelines.
Dominique Sydow   +3 more
doaj   +1 more source

Insulin sensitivity in critically ill patients: are women more insulin resistant?

open access: yesAnnals of Intensive Care, 2021
Background Glycaemic control (GC) in intensive care unit is challenging due to significant inter- and intra-patient variability, leading to increased risk of hypoglycaemia. Recent work showed higher insulin resistance in female preterm neonates.
Vincent Uyttendaele   +5 more
doaj   +1 more source

SwissADME and pkCSM Webservers Predictors: an integrated Online Platform for Accurate and Comprehensive Predictions for In Silico ADME/T Properties of Artemisinin and its Derivatives

open access: yesKompleksnoe ispolʹzovanie mineralʹnogo syrʹâ/Complex Use of Mineral Resources/Mineraldik shikisattardy Keshendi Paidalanu, 2022
In vivo ADME testing is costly, time-consuming, and puts animal lives at risk, whereas in silico ADME testing is safer, simpler, and faster. This study will use in silico methodologies from SwissADME and pkCSM as an integrated online platform for ...
K. A. Al Azzam
semanticscholar   +1 more source

In Silico ADME/Tox Comes of Age: Twenty Years Later

open access: yesXenobiotica; the fate of foreign compounds in biological systems, 2023
In the early 2000s pharmaceutical drug discovery was beginning to use computational approaches for absorption, distribution, metabolism, excretion and toxicity (ADME/Tox, also known as ADMET) prediction.
S. Ekins   +3 more
semanticscholar   +1 more source

Reducing the Complexity of Musculoskeletal Models Using Gaussian Process Emulators

open access: yesApplied Sciences, 2022
Musculoskeletal models (MSKMs) are used to estimate the muscle and joint forces involved in human locomotion, often associated with the onset of degenerative musculoskeletal pathologies (e.g., osteoarthritis).
Ivan Benemerito   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy